Informing selection of drugs for COVID-19 treatment through adverse events analysis
Abstract Coronavirus disease 2019 (COVID-19) is an ongoing pandemic and there is an urgent need for safe and effective drugs for COVID-19 treatment. Since developing a new drug is time consuming, many approved or investigational drugs have been repurposed for COVID-19 treatment in clinical trials. T...
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Nature Portfolio
2021
|
| Subjects: | |
| Online Access: | https://doaj.org/article/cec1715e9fd24f53a1ff4e77983d08f9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|